A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
Clinical trial NCT05456425 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05456425
- Sponsor
- Cloudbreak Therapeutics, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2026-12-31
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.